TRMK trades 1.9% above Wall Street's consensus target of $45.50.
Last 12 months price action with 12-month analyst target path
The base valuation assumes TRMK achieves its forward estimates and maintains a stable P/E multiple of 11.9x. This scenario reflects the blended consensus of 9 Wall Street analysts, balancing both positive catalysts and macroeconomic headwinds over the next 12 months.
As of July 6, 2026, Trustmark Corporation (TRMK) has a Wall Street consensus price target of $45.50, based on estimates from 9 covering analysts. With the stock currently trading at $46.38, this represents a potential downside of -1.9%. The company has a market capitalization of $2.72B.
Analyst price targets range from a low of $45.50 to a high of $45.50, representing a 0% spread in expectations. The median target of $45.50 aligns closely with the consensus average. The tight target dispersion indicates high conviction among analysts.
The current analyst consensus rating is Hold, with 0 analysts rating the stock as a Buy or Strong Buy,7 rating it Hold, and 2 rating it Sell or Strong Sell. The bearish sentiment suggests caution about the stock at current levels.
From a valuation perspective, TRMK trades at a trailing P/E of 12.5x and forward P/E of 11.9x. The forward PEG ratio of 1.47 indicates reasonable valuation for growth. Analysts expect EPS to grow +1.8% over the next year.
Our proprietary valuation model, which blends historical multiples with forward estimates, suggests a base-case price target of $54.49, with bear and bull scenarios of $34.33 and $71.79 respectively. Model confidence stands at 50/100, reflecting moderate uncertainty in projections.
| Company | Market Cap | Price | Target | Upside Potential | Rating | Fwd P/E | Analysts |
|---|---|---|---|---|---|---|---|
HOMBHome Bancshares, Inc. | $5.8B | $28.68 | $31.50 | +9.8% | Hold | 11.6x | 19 |
SFNCSimmons First National Corporation | $3.3B | $22.84 | $23.50 | +2.9% | Buy | 11.0x | 9 |
HOPEHope Bancorp, Inc. | $1.7B | $13.58 | $14.50 | +6.8% | Hold | 12.2x | 6 |
IBCPIndependent Bank Corporation | $743M | $36.04 | $38.00 | +5.4% | Hold | 10.1x | 7 |
RNSTRenasant Corporation | $4.0B | $42.98 | $38.80 | -9.7% | Buy | 11.5x | 16 |
FFINFirst Financial Bankshares, Inc. | $5.0B | $34.88 | $39.25 | +12.5% | Hold | 17.1x | 15 |
BOKFBOK Financial Corporation | $8.5B | $139.29 | $132.00 | -5.2% | Hold | 13.5x | 21 |
UMBFUMB Financial Corporation | $10.9B | $143.80 | $152.71 | +6.2% | Buy | 11.1x | 18 |
CVBFCVB Financial Corp. | $3.1B | $22.81 | $26.00 | +14.0% | Hold | 15.8x | 16 |
BANRBanner Corporation | $2.3B | $67.17 | $64.25 | -4.3% | Hold | 10.9x | 13 |
Quick answers to the most common questions about buying TRMK stock.
Wall Street's consensus price target for TRMK is $45.5, -1.9% from its current price of $46.38. The below-market target from 9 analysts suggests limited near-term appreciation.
TRMK has a consensus rating of "Hold" based on 9 Wall Street analysts. The rating breakdown is leaning bearish, with 2 Sell/Strong Sell ratings. The consensus 12-month price target of $45.5 implies -1.9% downside from current levels.
With a forward P/E of 11.8771x, TRMK trades at a relatively low valuation. The consensus target of $45.5 implies -1.9% move, suggesting the market may be pricing in risks.
The most bullish Wall Street analyst has a price target of $45.5 for TRMK, while the most conservative target is $45.5. The consensus of $45.5 represents the median expectation. Our quantitative valuation model projects a bull case target of $72 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.
TRMK is moderately covered, with 9 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 0 have Buy ratings, 7 recommend Hold, and 2 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.
The 12-month TRMK stock forecast based on 9 Wall Street analysts shows a consensus price target of $45.5, with estimates ranging from $45.5 (bear case) to $45.5 (bull case). The median consensus rating is "Hold". Our proprietary valuation model produces a base case fair value of $54, with bear/bull scenarios of $34/$72.
Our quantitative valuation model calculates TRMK's fair value at $54 (base case), with a bear case of $34 and bull case of $72. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 50/100.
TRMK trades at a forward P/E ratio of 11.9x based on next-twelve-months earnings estimates compared to a trailing P/E of 12.5x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.
Analysts are cautious on TRMK, with 2 Sell ratings and a price target of $45.5 (-1.9% from current price). The "Hold" consensus suggests careful evaluation before buying. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.
TRMK analyst price targets range from $45.5 to $45.5, a 0% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $45.5 consensus represents the middle ground. Our model's $34-$72 range provides an independent fundamental perspective.
DCF models, multiple analysis, and analyst estimates.
10-year return with dividends reinvested.
See how regular investing compounds over time.
Compare growth, multiples, and margins vs sector.